Ctriporin, a new anti-methicillin-resistant Staphylococcus aureus peptide from the venom of the scorpion Chaerilus tricostatus

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 11, 2011, Pages 5220-5229

  Fan, Zheng ^a   Cao, Luyang ^a   He, Yawen ^a   Hu, Jun ^a   Di, Zhiyong ^a   Wu, Yingliang ^a   Li, Wenxin ^a   Cao, Zhijian ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CTRIPORIN; PLACEBO; SCORPION VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACILLUS THURINGIENSIS; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL STRAIN; CANDIDA ALBICANS; CHAERILUS TRICOSTATUS; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOLYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORPION; SEQUENCE ANALYSIS; SKIN INFECTION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTI-BACTERIAL AGENTS; FEMALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PEPTIDES; SCORPIONS; SKIN DISEASES, INFECTIOUS; STAPHYLOCOCCAL INFECTIONS; VENOMS;

EID: 80054708836     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00369-11     Document Type: Article

References (53)

1. Andres, E., and J. L. Dimarcq. 2004. Cationic antimicrobial peptides: update of clinical development. J. Intern. Med. 255:519-520. (Pubitemid 38446366)
2. Appelbaum, P. C. 2006. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 12(Suppl. 1):16-23.
3. Appelbaum, P. C. 2007. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int. J. Antimicrob. Agents 30:398-408. (Pubitemid 47498971)
4. Baggett, H. C., et al. 2003. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect. Control Hosp. Epidemiol. 24:397-402. (Pubitemid 36818506)
5. Birnbaum, R. S., J. A. O'Neil, M. Muszynski, D. C. Aron, and B. A. Roos. 1982. A non-calcitonin secretory peptide derived from preprocalcitonin. J. Biol. Chem. 257:241-244. (Pubitemid 12109774)
6. Bradbury, A. F., and D. G. Smyth. 1991. Peptide amidation. Trends Biochem. Sci. 16:112-115. (Pubitemid 121004415)
7. Braff, M. H., M. Zaiou, J. Fierer, V. Nizet, and R. L. Gallo. 2005. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect. Immun. 73:6771-6781. (Pubitemid 41368844)
8. Cociancich, S., et al. 1993. Purification and characterization of a scorpion defensin, a 4-kDa antibacterial peptide presenting structural similarities with insect defensins and scorpion toxins. Biochem. Biophys. Res. Commun. 194:17-22. (Pubitemid 23237894)
9. Cohen, P. R. 2005. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. South Med. J. 98:596-602. (Pubitemid 40848097)
10. Cole, A. M., et al. 2001. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97:297-304. (Pubitemid 32061273)
11. Conde, R., F. Z. Zamudio, M. H. Rodriguez, and L. D. Possani. 2000. Scorpine, an anti-malaria and antibacterial agent purified from scorpion venom. FEBS Lett. 471:165-168. (Pubitemid 30190058)
12. Corzo, G., et al. 2001. Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem. J. 359:35-45. (Pubitemid 32939205)
13. Dai, C., et al. 2008. Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob. Agents Chemother. 52:3967-3972.
14. Dai, L., et al. 2001. IsCT, a novel cytotoxic linear peptide from scorpion Opisthacanthus madagascariensis. Biochem. Biophys. Res. Commun. 286:820-825. (Pubitemid 32912961)
15. Dai, T., G. P. Tegos, T. Zhiyentayev, E. Mylonakis, and M. R. Hamblin. 2010. Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg. Med. 42:38-44.
16. David, M. Z., K. M. Rudolph, T. W. Hennessy, S. Boyle-Vavra, and R. S. Daum. 2008. Molecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern Alaska. Emerg. Infect. Dis. 14:1693-1699.
17. Deurenberg, R. H., et al. 2007. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 13:222-235. (Pubitemid 46603352)
18. Diamond, G., N. Beckloff, A. Weinberg, and K. O. Kisich. 2009. The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 15:2377-2392.
19. Douglass, J., O. Civelli, and E. Herbert. 1984. Polyprotein gene expression: generation of diversity of neuroendocrine peptides. Annu. Rev. Biochem. 53:665-715.
20. Ehret-Sabatier, L., et al. 1996. Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood. J. Biol. Chem. 271:29537-29544. (Pubitemid 26389572)
21. Enright, M. C., et al. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. U. S. A. 99:7687-7692. (Pubitemid 34568752)
22. Finlay, B. B., and R. E. Hancock. 2004. Can. innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2:497-504. (Pubitemid 39200016)
23. Fritsche, T. R., P. R. Rhomberg, H. S. Sader, and R. N. Jones. 2008. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. J. Antimicrob. Chemother. 61:1092-1098. (Pubitemid 351524455)
24. Fuchs, P. C., A. L. Barry, and S. D. Brown. 1998. In vitro antimicrobial activity of MSI-78, a magainin analog. Antimicrob. Agents Chemother. 42:1213-1216. (Pubitemid 28227922)
25. Groom, A. V., et al. 2001. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286:1201-1205. (Pubitemid 33015549)
26. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557. (Pubitemid 44967479)
27. Isaac, R., et al. 1998. A novel peptide-processing activity of insect peptidyl-dipeptidase A (angiotensin I-converting enzyme): the hydrolysis of lysyl-arginine and arginyl-arginine from the C terminus of an insect prohormone peptide. Biochem. J. 330(Pt. 1):61-65.
28. Jenssen, H., P. Hamill, and R. E. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511. (Pubitemid 44137212)
29. Kock, R., et al. 2010. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Eur. Surveill. 15:19688.
30. Kupstaite, R., et al. 2010. Severe vancomycin-induced anaphylactic reaction. Medicina (Kaunas) 46:30-33.
31. Lee, D. Y., et al. 2008. Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J. Invest. Dermatol. 128:1863-1866.
32. Luo, F., et al. 2005. Genomic organization of four novel non-disulfide-bridged peptides from scorpion Mesobuthus martensii Karsch: gaining insight into evolutionary mechanism. Peptides 26:2427-2433. (Pubitemid 41676713)
33. Marothi, Y. A., H. Agnihotri, and D. Dubey. 2005. Enterococcal resistance: an overview. Indian J. Med. Microbiol. 23:214-219.
34. Martin, E., T. Ganz, and R. I. Lehrer. 1995. Defensins and other endogenous peptide antibiotics of vertebrates. J. Leukoc. Biol. 58:128-136.
35. Nair, R. B. 1980. Chemical nature of toxic protein of venom of the South Indian scorpion Heterometrus scaber. Indian J. Exp. Biol. 18:1142-1144.
36. Nemati, M., et al. 2008. Antimicrobial resistance of old and recent Staphylococcus aureus isolates from poultry: first detection of livestock-associated methicillin-resistant strain ST398. Antimicrob. Agents Chemother. 52:3817-3819.
37. Ong, P. Y., et al. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151-1160.
38. Ortega, M. R., T. Ganz, and S. M. Milner. 2000. Human beta defensin is absent in burn blister fluid. Burns 26:724-726.
39. Oyston, P. C., M. A. Fox, S. J. Richards, and G. C. Clark. 2009. Novel peptide therapeutics for treatment of infections. J. Med. Microbiol. 58:977-987.
40. Parisien, A., B. Allain, J. Zhang, R. Mandeville, and C. Q. Lan. 2008. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J. Appl. Microbiol. 104:1-13. (Pubitemid 350265294)
41. Petricevich, V. L. 2006. Balance between pro- and anti-inflammatory cytokines in mice treated with Centruroides noxius scorpion venom. Mediators Inflamm. 2006:54273.
42. Petricevich, V. L., A. Hernandez Cruz, F. I. Coronas, and L. D. Possani. 2007. Toxin gamma from Tityus serrulatus scorpion venom plays an essential role in immunomodulation of macrophages. Toxicon 50:666-675. (Pubitemid 47411583)
43. Rouille, Y., et al. 1995. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front. Neuroendocrinol. 16:322-361.
44. Sader, H. S., K. A. Fedler, R. P. Rennie, S. Stevens, and R. N. Jones. 2004. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Antimicrob. Agents Chemother. 48:3112-3118. (Pubitemid 38989182)
45. Sang, Y., and F. Blecha. 2008. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics. Anim. Health Res. Rev. 9:227-235.
46. Stevens, A. M., et al. 2010. Methicillin-resistant Staphylococcus aureus carriage and risk factors for skin infections, Southwestern Alaska, U.S.A. Emerg. Infect. Dis. 16:797-803.
47. Torres-Larios, A., G. B. Gurrola, F. Z. Zamudio, and L. D. Possani. 2000. Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur. J. Biochem. 267:5023-5031. (Pubitemid 30641298)
48. Waness, A. 2010. Revisiting methicillin-resistant Staphylococcus aureus infections. J. Glob. Infect. Dis. 2:49-56.
49. Wang, Z., and G. Wang. 2004. APD: the antimicrobial peptide database. Nucleic Acids Res. 32:D590-D592. (Pubitemid 38081727)
50. Yamasaki, K., and R. L. Gallo. 2008. Antimicrobial peptides in human skin disease. Eur. J. Dermatol. 18:11-21. (Pubitemid 351158166)
51. Yuan, W., et al. 2010. Cloning and functional characterization of a new antimicrobial peptide gene StCT1 from the venom of the scorpion Scorpiops tibetanus. Peptides 31:22-26.
52. Zeh, D. W. 1990. The biology of scorpions. Science 249:1176-1177. (Review.)
53. Zhao, Z., et al. 2009. Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob. Agents Chemother. 53:3472-3477.